Skip to main content

Day: November 8, 2024

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

Written by Customer Service on . Posted in Public Companies.

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced eight presentations spanning its innovative portfolio of late-stage products and product candidates in psychiatry and neurology at NEI Congress 2024, being held Nov. 7 – Nov. 10, 2024, in Colorado Springs, Colorado. Details for the presentations are as follows: Major Depressive Disorder Title: AXS-05 (Auvelity®) in Major Depressive Disorder: Pooled Data from Two Six-Week Controlled Trials (GEMINI and ASCEND)Presentation Date and Time: Friday, Nov. 8, 3:35 – 4:30 p.m. ETLead Author: Craig Chepke, MD, SUNY Upstate Medical UniversityPoster Number: 101 Title: Effects of AXS-05 (Auvelity®) in Improving...

Continue reading

Onex Reports Third Quarter 2024 Results

Written by Customer Service on . Posted in Public Companies.

All amounts in U.S. dollars unless otherwise stated Launches substantial issuer bid for up to C$400 million of its Subordinated Voting Shares TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter and nine months ended September 30, 2024. In a separate news release issued today, Onex also announced that it has commenced a Substantial Issuer Bid. “We are advancing our strategic plan focused on value creation, accelerating profitability and the long-term compounding of our investing capital,” said Bobby Le Blanc, CEO and President. “The third quarter was marked by continued growth in investing capital per share and successful investing and realization activity across our platforms. The launch of a substantial issuer bid reflects our confidence in the inherent...

Continue reading

Seer to Participate in Upcoming November Investor Conferences

Written by Customer Service on . Posted in Public Companies.

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences:Guggenheim Inaugural Healthcare Innovation Conference in Boston, MAFireside chat on Monday, November 11th at 11:30 a.m. Eastern Time Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NYFireside chat on Thursday, November 21st at 10:00 a.m. Eastern TimeLive webcasts of the sessions will be available on the Investor section of Seer’s website at investor.seer.bio. Archived replays will be available on the company’s website following the conference. About SeerSeer is a life sciences company developing transformative products that open...

Continue reading

Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024

Written by Customer Service on . Posted in Public Companies.

HOUSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, November 15, 2024 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2024 and to provide a business overview. To access the live conference call, please call (844) 481-3014 (domestic) or (412) 317-1879 (international) at least five minutes prior to the start time. A live audio webcast of the call will also be available on the Presentations section of the Company’s website, www.biopathholdings.com. An archived webcast will be available on the Bio-Path website approximately...

Continue reading

Velocity One Signs Merger Agreement with EMCORE (EMKR)

Written by Customer Service on . Posted in Mergers And Acquisitions.

Transaction will unite industry leaders to create an emerging force in the aerospace and defense industry FAIRFIELD, New Jersey, Nov. 08, 2024 (GLOBE NEWSWIRE) — Velocity One, a newly formed aerospace manufacturing holding company, announced today it has signed a merger agreement with EMCORE Corporation (Nasdaq: EMKR) (“EMCORE”), a provider of inertial navigation solutions to the aerospace and defense industry. Under the agreement, EMCORE will become a wholly owned subsidiary of Velocity One. The purchase price of $3.10 per share in cash, backed by Charlesbank Capital Partners (“Charlesbank”), a private investment firm with more than $22 billion of total assets*, has been unanimously approved by the EMCORE board of directors. Velocity One will now have three industry leaders operating under its wing. In addition to EMCORE, it will...

Continue reading

Perella Weinberg Reports Third Quarter 2024 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Financial Overview – Third QuarterRevenues of $278 Million, Up 100% From a Year Ago Adjusted Pre-Tax Income of $52 Million, GAAP Pre-Tax Income of $36 Million Adjusted EPS of $0.34; GAAP Diluted EPS of $0.24Financial Overview – Nine MonthsRevenues of $652 Million, Up 50% From a Year Ago Adjusted Pre-Tax Income of $97 Million, GAAP Pre-Tax Loss of $(96) Million Adjusted EPS of $0.69; GAAP Diluted EPS of $(1.61)Talent InvestmentYear-to-Date Added Five New Partners and Eleven New Managing DirectorsCapital ManagementStrong Balance Sheet with $335 Million of Cash, Cash Equivalents and Short-Term Investments and No Debt Year-to-Date Retired Approximately 12.3 Million Shares and Share Equivalents through Purchase, Exchange and Net Settlement Year-to-Date Returned $215 Million to Equity Holders Declared Quarterly Dividend...

Continue reading

Brookfield Renewable Announces Record Third Quarter Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

All amounts in U.S. dollars unless otherwise indicated BROOKFIELD, News, Nov. 08, 2024 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable Partners”, “BEP“) today reported financial results for the three and nine months ended September 30, 2024. “We had another successful quarter highlighted by agreements to monetize several assets, crystallizing strong returns and generating significant funds to deploy into future growth. We also signed numerous favorable large-scale contracts within our North American hydro portfolio during the quarter that will enable us to execute upfinancings providing additional capital to invest in the current attractive environment,” said Connor Teskey, CEO of Brookfield Renewable. “These initiatives continue to demonstrate our sustainable...

Continue reading

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Generated record quarterly net revenues of $148.3 million, representing year-over-year growth of 12.5%, and record Purified Cortrophin® Gel net revenues of $52.6 million, an increase of 76.8% year-over-year Net loss of $(24.2) million and adjusted non-GAAP EBITDA of $35.1 million Diluted GAAP loss per share of $(1.27) and adjusted non-GAAP diluted earnings per share of $1.34 Completed the acquisition of Alimera Sciences, Inc. on September 16, 2024, adding two commercial assets ILUVIEN® and YUTIQ® with significant growth potential to its Rare Disease portfolio Implemented new capital structure that is expected to reduce interest expense by approximately $39.0 million on an annualized basis (1) Increased 2024 guidance with expected net revenues of $594 million to $602 million, adjusted non-GAAP EBITDA of $149 million to $153 million and...

Continue reading

TransUnion Declares Third Quarter 2024 Dividend of $0.105 per Share

Written by Customer Service on . Posted in Dividend Reports And Estimates.

CHICAGO, Nov. 08, 2024 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash dividend of $0.105 per share for the third quarter 2024. The dividend will be payable on December 9, 2024, to shareholders of record on November 22, 2024. About TransUnion (NYSE: TRU) TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics....

Continue reading

Ocugen Provides Business Update with Third Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Conference Call and Webcast Today at 8:30 a.m. ETSubsequent to quarter-end, closed $30 million in debt financing OCU400 Phase 3 liMeliGhT clinical trial for retinitis pigmentosa (RP) on track to complete enrollment in 1H2025 OCU410 is currently in Phase 2 of the Phase 1/2 ArMaDa clinical trial Data and Safety Monitoring Board (DSMB) for the OCU410ST GARDian clinical trial approved enrollment for the second phase of the Phase 1/2 clinical trial New data on Phase 1/2 clinical trials for OCU410, OCU410ST and OCU400 to be presented at upcoming Clinical ShowcaseMALVERN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today reported third quarter 2024 financial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.